Søgeresultater - Gaurav Shah

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience

    Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience af James C. Yao, Alexandria T. Phan, Valentine Jehl, Gaurav Shah, Funda Meric‐Bernstam

    Udgivet 2013
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    Rationale for the development of IMC‐3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet‐derived growth factor receptor α

    Rationale for the development of IMC‐3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet‐derived growth factor receptor α af Gaurav Shah, Nick Loizos, Hagop Youssoufian, Jonathan D. Schwartz, Eric K. Rowinsky

    Udgivet 2010
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas1

    Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas1 af Gaurav Shah, Santosh Kesari, Ronghui Xu, Tracy T. Batchelor, Alison M. O'Neill, Fred H. Hochberg, Brenda Levy, J. Bradshaw, Patrick Y. Wen

    Udgivet 2006
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

    Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma af Gaurav Shah, Joachim Yahalom, Denise D. Correa, Rose Lai, Jeffrey J. Raizer, David Schiff, Renato V. LaRocca, Barbara Grant, Lisa M. DeAngelis, Lauren E. Abrey

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final... af Patrick G. Morris, Denise D. Correa, Joachim Yahalom, Jeffrey J. Raizer, David Schiff, Barbara Grant, Sean Grimm, Rose Lai, Anne S. Reiner, K. Panageas, Sasan Karimi, Richard Curry, Gaurav Shah, Lauren E. Abrey, Lisa M. DeAngelis, Antonio Omuro

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Sustained Remissions Following Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed or Refractory CD19+ Lymphomas

    Sustained Remissions Following Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed or Refractory CD19+ Lymphomas af Stephen J. Schuster, Jakub Svoboda, Sunita D. Nasta, David Porter, Elise A. Chong, Daniel J. Landsburg, Anthony R. Mato, Simon F. Lacey, Jan J. Melenhorst, Anne Chew, Jens Hasskarl, Gaurav Shah, Mariusz A. Wasik, Katherine T. Marcucci, Zhaohui Zheng, Bruce L. Levine, Carl H. June

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

    Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial af William D. Tap, Robin L. Jones, Brian A. Van Tine, Bartosz Chmielowski, Anthony Elias, Douglas Adkins, Mark Agulnik, Matthew M. Cooney, Michael B. Livingston, Gregory Pennock, Meera Hameed, Gaurav Shah, Amy Qin, Ashwin Shahir, Damien M. Cronier, Robert Ilaria, Ilaria Conti, Jan Cosaert, Gary K. Schwartz

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: